A novel e8a2 BCR–ABL1 fusion with insertion of RALGPS1 exon 8 in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia

Approximately 25–30% of adult patients with acute lymphoblastic leukemia have evidence of the Philadelphia chromosome (Ph+ ALL), with allogeneic stem cell transplant, if a patient is eligible, curr...